Essex Financial Services Inc. boosted its position in Allergan PLC (NYSE:AGN) by 25.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,580 shares of the company’s stock after buying an additional 324 shares during the period. Essex Financial Services Inc.’s holdings in Allergan PLC were worth $365,000 at the end of the most recent reporting period.
Several other large investors have also recently bought and sold shares of AGN. AMP Capital Investors Ltd increased its stake in Allergan PLC by 4.9% in the first quarter. AMP Capital Investors Ltd now owns 163,096 shares of the company’s stock worth $44,844,000 after buying an additional 7,588 shares in the last quarter. Arizona State Retirement System increased its stake in Allergan PLC by 0.9% in the first quarter. Arizona State Retirement System now owns 108,577 shares of the company’s stock worth $29,102,000 after buying an additional 1,000 shares in the last quarter. Montag & Caldwell LLC increased its stake in Allergan PLC by 16.2% in the second quarter. Montag & Caldwell LLC now owns 687,035 shares of the company’s stock worth $158,767,000 after buying an additional 95,951 shares in the last quarter. Intermede Investment Partners Ltd purchased a new stake in Allergan PLC during the second quarter worth approximately $37,790,000. Finally, Johnston Asset Management LLC purchased a new stake in Allergan PLC during the second quarter worth approximately $134,170,000. Institutional investors own 85.20% of the company’s stock.
Allergan PLC (NYSE:AGN) traded up 1.76% during trading on Tuesday, hitting $227.94. The company had a trading volume of 4,294,607 shares. Allergan PLC has a 52-week low of $195.50 and a 52-week high of $322.68. The firm’s 50 day moving average is $237.35 and its 200-day moving average is $237.14. The stock has a market capitalization of $90.25 billion, a price-to-earnings ratio of 21.70 and a beta of 0.81.
Allergan PLC (NYSE:AGN) last posted its earnings results on Monday, August 8th. The company reported $3.35 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $3.34 by $0.01. Allergan PLC had a net margin of 28.06% and a return on equity of 7.67%. The firm earned $3.68 billion during the quarter, compared to the consensus estimate of $4.10 billion. The firm’s revenue for the quarter was up 1.0% on a year-over-year basis. During the same quarter last year, the firm earned $4.41 EPS. On average, equities analysts forecast that Allergan PLC will post $14.00 earnings per share for the current year.
AGN has been the topic of several analyst reports. Mizuho reduced their price objective on Allergan PLC from $305.00 to $299.00 and set a “buy” rating on the stock in a research note on Tuesday, October 11th. Vetr raised Allergan PLC from a “buy” rating to a “strong-buy” rating and set a $288.87 price objective on the stock in a research note on Monday, August 22nd. Goldman Sachs Group Inc. reissued a “buy” rating and set a $300.00 price objective on shares of Allergan PLC in a research note on Tuesday, September 27th. Argus reissued a “buy” rating and set a $340.00 price objective on shares of Allergan PLC in a research note on Tuesday, October 4th. Finally, Bank of America Corp. set a $294.00 price objective on Allergan PLC and gave the stock a “buy” rating in a research note on Tuesday, September 20th. Six investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the company. Allergan PLC has an average rating of “Buy” and a consensus price target of $302.23.
Allergan PLC Company Profile
Allergan, Inc is a multi-specialty healthcare company. The Company focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter (OTC) products. It discovers, develops and commercializes a range of products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets.
Want to see what other hedge funds are holding AGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allergan PLC (NYSE:AGN).
Receive News & Ratings for Allergan PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergan PLC and related companies with MarketBeat.com's FREE daily email newsletter.